Clinical Trial Update: Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome [NA]

View source ↗

Summary

A clinical trial evaluating cardiopulmonary rehabilitation for post-acute COVID-19 syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Taipei Medical University Shuang Ho Hospital | Conditions: Post Acute COVID-19 Syndrome | NA | Status: WITHDRAWN